Cargando…
The Prolyl Isomerase Pin1 Acts Synergistically with CDK2 to Regulate the Basal Activity of Estrogen Receptor α in Breast Cancer
In hormone receptor-positive breast cancers, most tumors in the early stages of development depend on the activity of the estrogen receptor and its ligand, estradiol. Anti-estrogens, such as tamoxifen, have been used as the first line of therapy for over three decades due to the fact that they elici...
Autores principales: | Lucchetti, Chiara, Caligiuri, Isabella, Toffoli, Giuseppe, Giordano, Antonio, Rizzolio, Flavio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3563590/ https://www.ncbi.nlm.nih.gov/pubmed/23390529 http://dx.doi.org/10.1371/journal.pone.0055355 |
Ejemplares similares
-
pRb controls Estrogen Receptor alpha protein stability and activity
por: Caligiuri, Isabella, et al.
Publicado: (2013) -
Editorial: Peptidyl-Prolyl Isomerases in Human Pathologies
por: Tuccinardi, Tiziano, et al.
Publicado: (2019) -
Pathological Role of Peptidyl-Prolyl Isomerase Pin1 in the Disruption of Synaptic Plasticity in Alzheimer's Disease
por: Xu, Lingyan, et al.
Publicado: (2017) -
The prolyl isomerase Pin1 in breast development and cancer
por: Wulf, Gerburg, et al.
Publicado: (2003) -
Post-translational Modifications of the Peptidyl-Prolyl Isomerase Pin1
por: Chen, Dongmei, et al.
Publicado: (2020)